Srinivas Viswanathan, MD, PhD, is an Assistant Professor of Medicine at Harvard Medical School and a medical oncologist at Dana-Farber Cancer Institute. Dr. Viswanathan completed his undergraduate studies at Yale University and received his MD and PhD degrees from Harvard Medical School, where his graduate training was in the lab of Dr. George Q. Daley. He completed a residency in Internal Medicine at Massachusetts General Hospital followed by a fellowship in Hematology/Oncology through the Dana-Farber/Mass General Brigham program. His postdoctoral research was at the Dana-Farber Cancer Institute and Broad Institute in the lab of Dr. Matthew Meyerson. His recognitions include the Harold M. Weintraub Graduate Student Award, the Leon Reznick Memorial Price for Excellence in Research from Harvard Medical School, Young Investigator Awards from the American Society for Clinical Oncology and the Prostate Cancer Foundation, a Clinician-Scientist Development Award from the Doris Duke Charitable Foundation, and a Damon Runyon-Rachleff Innovation Award. Dr. Viswanathan started his laboratory at the Dana-Farber Cancer Institute in 2019 and is focused on leveraging genomic and functional genetic technologies to dissect the mechanistic underpinnings and vulnerabilities of genitourinary cancers.